Maria Sharapova is suspended from tennis after failing drugs test

Maria Sharapova dropped a huge bombshell onto world tennis tonight when she admitted she had tested positive for a banned substance at January’s Australian Open.

Applying her legendary calm and determination, the five-times Grand Slam champion made a personal statement at a Los Angeles hotel confessing she had been caught out by tennis’s anti-doping operation.

The highest earning athlete in any female sport said that she had been found to have taken Mildronate – or Meldonium – which was prohibited from January 1 this year.

The International Tennis Federation has confirmed the star will be provisionally suspended from the sport March 12.

31F3EBA500000578-3480964-Speculation_was_rife_that_the_2004_Wimbledon_champion_pictured_w-a-41_1457381482828

At a press conference which many assumed would be to announce her retirement after a spate of injuries, she delivered what is catastrophic news for her, the sport and women’s tennis in particular.

‘I had legally been taking this for ten years,’ said Sharapova, who conceded that she had received a notification from the International Tennis Federation on December 22 that it was being outlawed. She admitted that she did not follow an information link that was provided.

‘I take responsibility for my professionalism in my job and I made a big mistake. I know there will be consequences and I don’t want to end my career this way. I really hope I will be given another chance to play tennis again. I can’t blame anyone but myself. I have let my fans down.

‘I know many of you thought I was retiring but if I was ever going to announce my retirement it would probably not be in a downtown Lost Angeles hotel with this fairly ugly carpet.’

‘It made me healthy and that is why I continued to take it,’ Sharapova said of the banned substance after taking a small number of questions from the floor.

Continue from page 2

 

Related Post

Share ThisEmail this to someonePin on PinterestPrint this pageShare on FacebookShare on Google+Tweet about this on Twitter
Share on LinkedIn

Be the first to comment

Leave a Reply

Facebook
Get More News and Stories Like This In Your Email
We respect your privacy.
%d bloggers like this: